Experience

MagIC Lifescience

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Chief Commercial Officer

  • May 2022 - Present



International Medical

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Director

  • Aug 2001 - Present

  US FDA Agent Services for Foreign Establishments • Communication between the FDA and the foreign establishment as the official correspondent • Providing FDA with information about foreign establishment's devices imported into the US • Scheduling FDA inspections of the foreign establishment • Establishment Registration, Medical Device Listing, and FDA 510(k) Submission • Medical device labeling US FDA Agent Services for Foreign Establishments • Communication between the FDA and the foreign establishment as the official correspondent • Providing FDA with information about foreign establishment's devices imported into the US • Scheduling FDA inspections of the foreign establishment • Establishment Registration, Medical Device Listing, and FDA 510(k) Submission • Medical device labeling



OncoGenesis Inc.

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Chief Commercial Officer

  • Oct 2020 - May 2022

  Recruited by the founders to get funded and lead the company from R&D development effort into a commercialized entity ready to launch the CE marked iPap®, the world’s first cervical specimen self-collector to increase cervical cancer screening participation and enable HPV as well as cytology screening that requires a cervical specimen. • Creating the strategy, strategic relationships, marketing materials, and setting up distribution Recruited by the founders to get funded and lead the company from R&D development effort into a commercialized entity ready to launch the CE marked iPap®, the world’s first cervical specimen self-collector to increase cervical cancer screening participation and enable HPV as well as cytology screening that requires a cervical specimen. • Creating the strategy, strategic relationships, marketing materials, and setting up distribution



KoruBio Inc

• San Diego, CA USA

• Chief Commercial Officer

  • Sep 2016 - Aug 2019

  • Negotiated agreement to custom design, develop and confirm next-generation DNA/RNA amplification KoruPlex™ assays for Rapid Diagnostics ML Limited’s MiniLab Platform purchased from Enigma Diagnostics. • Set up a laboratory at JLABS incubator in San Diego for assay development • Negotiated agreement to custom design, develop and confirm next-generation DNA/RNA amplification KoruPlex™ assays for Rapid Diagnostics ML Limited’s MiniLab Platform purchased from Enigma Diagnostics. • Set up a laboratory at JLABS incubator in San Diego for assay development



Enigma Diagnostics Ltd. (acquired by Rapid Diagnostics ML Ltd)

• London, England, United Kingdom

• Commercial Director

  • Oct 2014 - Sep 2016

  • Developed commercial strategy, set up distribution, supported clinical evaluations with KOLs at teaching medical centers across Europe and launched the CE marked MiniLab Point-of-Care molecular diagnostic platform. • The MiniLab was well-received; however, the company suffered from assay contamination during manufacturing and was unable to supply cartridges. • Developed commercial strategy, set up distribution, supported clinical evaluations with KOLs at teaching medical centers across Europe and launched the CE marked MiniLab Point-of-Care molecular diagnostic platform. • The MiniLab was well-received; however, the company suffered from assay contamination during manufacturing and was unable to supply cartridges.



ApolloDx (rebranded to Reliable-LFC, LLC)

• Salt Lake City, UT

• VP Business Development

  • Sep 2012 - Oct 2014

  • Recruited by the CEO of a self-funded start-up to develop the product requirements for a handheld diagnostic platform and obtained government funding for product development • Shareholder of Reliable-LFC, LLC, Grand Prize Winner of the $6M XPRIZE Rapid COVID Testing Competition • Recruited by the CEO of a self-funded start-up to develop the product requirements for a handheld diagnostic platform and obtained government funding for product development • Shareholder of Reliable-LFC, LLC, Grand Prize Winner of the $6M XPRIZE Rapid COVID Testing Competition



BioFire Diagnostics, LLC

• United States
• Medical Equipment Manufacturing
• 700 & Above Employee

• Director, Sales & Marketing

  • Feb 2010 - Sep 2012

  Recruited by the executive management team of 21-year-old privately-held company, to bring in other revenue streams besides PCR licensing agreements and government contracts plus prepare to launch a diagnostic platform. • In 2010, increased revenue from $12M to $18M while preparing to launch the FilmArray that was cleared mid-2011. In 2011, the total revenue was $35M. • In 2012, revenue increased to $65M, which was 135% of the forecast. • In 2010, started with five direct reports. By 2012, the commercial team included seventeen direct reports and greater than forty international distributors. • Hired, trained, mentored, and led the commercial team that launched the FilmArray. • Created the strategic commercial plan, product roadmap, materials, and programs that accelerated the FilmArray sales cycle compelling laboratory directors to provide infectious disease physicians with FilmArray's comprehensive results. These early adopters published and presented their clinical data endorsing the merits of syndromic testing required for the early majority to purchase FilmArray Platforms.



BioMicro Systems, Inc.

• Biotechnology Research
• 1 - 100 Employee

• Director, Sales & Marketing

  • Jan 2008 - Feb 2010

  Recruited by President/CEO to bring shareholder value and investor exit for VC-funded 8-year-old company. • Increased revenue over two years from $5M to $13M of MAUI Microarray Hybridization Systems by forging strategic business relationships with Roche NimbleGen and Agilent. • Launched the companion MAUI Microarray Wash System that led to Roche Diagnostics acquiring the company. Recruited by President/CEO to bring shareholder value and investor exit for VC-funded 8-year-old company. • Increased revenue over two years from $5M to $13M of MAUI Microarray Hybridization Systems by forging strategic business relationships with Roche NimbleGen and Agilent. • Launched the companion MAUI Microarray Wash System that led to Roche Diagnostics acquiring the company.



Empi (acquired by DJO Global)

• St. Paul, MN USA

• Director, Sales & Marketing

  • Aug 2007 - Jan 2008

  After EMPI bought Iomed in August 2007, EMPI and McKinley & Company retained my services to spearhead the launch of the Hybresis System into a $100M market using their commercial team of >300 plus a $1.1M budget • Created strategic commercial plan, budget, promotional and training materials, and trained the team. After EMPI bought Iomed in August 2007, EMPI and McKinley & Company retained my services to spearhead the launch of the Hybresis System into a $100M market using their commercial team of >300 plus a $1.1M budget • Created strategic commercial plan, budget, promotional and training materials, and trained the team.



IOMED, Inc.

• Medical Equipment Manufacturing
• 1 - 100 Employee

• Director, Sales & Marketing

  • Jan 2002 - Aug 2007

  Recruited by President/CEO to increase stock value for a publicly-traded 20-year-old company that was weeks from delisting on AMEX. • Increased revenue and profitability within weeks that included negotiating large OEM contracts • Increased revenue from $5M to $22M without increasing headcount • Developed commercial strategic plans to bring shareholder value by making the company attractive for acquisition, due to shrinking reimbursement. Developed and launched the Hybresis System, which was a 2007 Innovation Award finalist • Launching the Hybresis System was the impetus for EMPI purchasing IOMED



Sorenson Medical, Inc. (acquired by Summit Medical Products, Inc., acquired by Avanos Medical, Inc.)

• Salt Lake City, UT

• VP, Sales & Marketing

  • Jul 1996 - Jan 2002

  Recruited by President and Board of Directors to join a privately-funded start-up of six people to develop the product requirement for a range of Microject Infusion Pumps, work with the product development and regulatory teams, launch four therapy-specific infusion pumps, and set up global distribution. • Built the team, set up distribution, and spearheaded global launch with five employees and over forty distributors • Negotiated strategic alliances to drive sales in new market segments through Arrow International, AstraZeneca, Codman, Knoll Pharma, and Zimmer Holdings • Revenue increased from $0 in 1996 to $35M in 2001 with international sales accounting for 70% of revenue



Gesco International (acquired by Bard Access Systems for $100MM)

• San Antonio, Texas, United States

• VP, Sales & Marketing

  • Feb 1993 - Jul 1996

  Recruited by the President/CEO to replicate my regional sales and marketing success. • Successfully created a new vascular access category, PICC lines, accounting for greater than $1B in current global sales. The Per-Q-Cath still accounts for 70% of the market share. • Successfully challenged eighteen states to include PICC Line placements within the scope of nursing practice. • Accelerated Per-Q-Cath sales by training and certifying nurses through the Train-the-Trainer workshops. • Increased revenue from $3M to $21.5M in three years and sold to Bard Access Systems for $100M.